Novogene Co., Ltd. (SHA:688315)
17.36
-0.65 (-3.61%)
Nov 17, 2026, 3:00 PM CST
| Market Cap | 7.03B +16.8% |
| Revenue (ttm) | 2.30B +5.8% |
| Net Income | 150.17M -14.3% |
| EPS | 0.37 -14.0% |
| Shares Out | 405.06M |
| PE Ratio | 46.84 |
| Forward PE | 37.47 |
| Dividend | 0.05 (0.26%) |
| Ex-Dividend Date | Jun 10, 2026 |
| Volume | 13,260,621 |
| Open | 17.74 |
| Previous Close | 18.01 |
| Day's Range | 17.20 - 18.20 |
| 52-Week Range | 11.46 - 23.43 |
| Beta | 0.76 |
| Analysts | Strong Buy |
| Price Target | 19.53 (+12.5%) |
| Earnings Date | Oct 29, 2026 |